Varenicline + Nicotine Patch + Placebo Patch + Placebo Tablet
ApprovedActive 0 views this week 0 watching⚡ Active
Interest: 47/100
47
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Tobacco Use Cessation
Conditions
Tobacco Use Cessation
Trial Timeline
Dec 14, 2015 → Feb 28, 2028
NCT ID
NCT02162849About Varenicline + Nicotine Patch + Placebo Patch + Placebo Tablet
Varenicline + Nicotine Patch + Placebo Patch + Placebo Tablet is a approved stage product being developed by Pfizer for Tobacco Use Cessation. The current trial status is active. This product is registered under clinical trial identifier NCT02162849. Target conditions include Tobacco Use Cessation.
What happened to similar drugs?
6 of 9 similar drugs in Tobacco Use Cessation were approved
Approved (6) Terminated (3) Active (2)
Hype Score Breakdown
Clinical
20
Activity
12
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02162849 | Approved | Active |
Competing Products
20 competing products in Tobacco Use Cessation